Globe Life (NYSE:GL) Posts Earnings Results, Misses Expectations By $0.06 EPS

Globe Life (NYSE:GL) posted its quarterly earnings data on Wednesday. The company reported $4.84 EPS for the quarter, missing the consensus estimate of $4.90 by ($0.06), Zacks reports. The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.56 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The firm’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the prior year, the company posted $4.81 earnings per share.

Globe Life Trading Down 0.2%

Shares of GL opened at $169.33 on Thursday. Globe Life has a 12-month low of $127.85 and a 12-month high of $191.55. The firm has a market capitalization of $13.01 billion, a P/E ratio of 11.24 and a beta of 0.44. The firm has a 50-day moving average price of $170.74 and a 200 day moving average price of $167.07. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43.

Globe Life Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Monday, October 5th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, October 5th. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. Globe Life’s payout ratio is presently 8.76%.

Globe Life announced that its Board of Directors has initiated a share buyback plan on Monday, August 10th that permits the company to repurchase $2.50 billion in outstanding shares. This repurchase authorization permits the company to repurchase up to 17.7% of its shares through open market purchases. Share repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.

Insider Activity

In other Globe Life news, EVP Robert Hensley sold 10,000 shares of the business’s stock in a transaction dated Tuesday, September 22nd. The shares were sold at an average price of $170.07, for a total value of $1,700,700.00. Following the transaction, the executive vice president directly owned 12,384 shares in the company, valued at $2,106,146.88. The trade was a 44.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Michael Majors sold 37,000 shares of the stock in a transaction that occurred on Wednesday, July 29th. The shares were sold at an average price of $178.64, for a total transaction of $6,609,680.00. Following the completion of the sale, the executive vice president directly owned 53,518 shares of the company’s stock, valued at approximately $9,560,455.52. This trade represents a 40.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 143,650 shares of company stock valued at $25,793,717 over the last three months. 2.11% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. JPMorgan Chase & Co. upped their target price on shares of Globe Life from $193.00 to $195.00 and gave the stock an “overweight” rating in a report on Thursday, October 15th. Jefferies Financial Group raised their price target on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research note on Friday, July 10th. Keefe, Bruyette & Woods lowered their price target on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a research report on Friday, July 24th. Piper Sandler upped their price objective on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. Finally, Morgan Stanley cut their price objective on shares of Globe Life from $208.00 to $197.00 and set an “overweight” rating for the company in a report on Monday, October 5th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $189.56.

Trending Headlines about Globe Life

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Third-quarter revenue rose 5.5% year over year to $1.60 billion, exceeding the $1.56 billion analyst consensus. Operating earnings were $4.84 per diluted share, slightly above the $4.81 reported a year earlier. Globe Life Inc. Reports Third Quarter 2026 Results
• Positive Sentiment: Globe Life continues to point to premium growth, higher investment income, artificial-intelligence adoption and agency expansion as longer-term growth drivers. These factors could support earnings and shareholder returns if execution remains on track. GL Gains From Premium Growth, AI Adoption and Higher Investment Income
• Neutral Sentiment: Globe Life posted a 19.58% net margin and 20.52% return on equity. Its valuation remains relatively moderate at about 11.2 times earnings, although the stock’s low beta suggests less sensitivity to broad market movements.
• Negative Sentiment: Operating EPS of $4.84 missed analyst estimates ranging from $4.87 to $4.90. Reported net income declined to $4.62 per share from $4.73 a year earlier, even as operating EPS edged higher. Globe Life Lags Q3 Earnings and Revenue Estimates
• Negative Sentiment: A $6.4 million underwriting loss and losses at Evry Health prompted Globe Life to cut its full-year guidance. The weaker outlook is likely the most important near-term negative catalyst because it raises concerns about underwriting performance and future earnings visibility. Evry Health Losses Force Globe Life to Cut Full-Year Guidance

About Globe Life

Globe Life Inc (NYSE: GL) is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.

The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.